This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2001 Jul 15;19(14):3303-5.

doi: 10.1200/JCO.2001.19.14.3303.

Menopause and breast cancer: addressing the secondary health effects of adjuvant chemotherapy

P A Ganz, G A Greendale

PMID: 11454876
DOI: 10.1200/JCO.2001.19.14.3303

Editorial

Menopause and breast cancer: addressing the secondary health effects of adjuvant chemotherapy

P A Ganz et al. J Clin Oncol. 2001.

. 2001 Jul 15;19(14):3303-5.

doi: 10.1200/JCO.2001.19.14.3303.

Authors

P A Ganz, G A Greendale

PMID: 11454876
DOI: 10.1200/JCO.2001.19.14.3303

No abstract available

PubMed Disclaimer

Comment on

Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer.
Bines J, Oleske DM, Cobleigh MA. Bines J, et al. J Clin Oncol. 1996 May;14(5):1718-29. doi: 10.1200/JCO.1996.14.5.1718. J Clin Oncol. 1996. PMID: 8622093 Review.
Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer.
Shapiro CL, Manola J, Leboff M. Shapiro CL, et al. J Clin Oncol. 2001 Jul 15;19(14):3306-11. doi: 10.1200/JCO.2001.19.14.3306. J Clin Oncol. 2001. PMID: 11454877

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information